interstitial lung disease
Showing NaN - NaN of 5
Pulmonary Hypertension, Interstitial Lung Disease, Combined Pulmonary Fibrosis and Emphysema Trial in Puerto Rico, United States
Completed
- Pulmonary Hypertension
- +2 more
- Inhaled Treprostinil
- Placebo
-
Birmingham, Alabama
- +96 more
Jul 21, 2022
Systemic Sclerosis, Diffuse Sclerosis Systemic, Interstitial Lung Disease Trial in Pittsburgh (Cyclophosphamide, Mesna,
Recruiting
- Systemic Sclerosis
- +3 more
- Cyclophosphamide
- +8 more
-
Pittsburgh, Pennsylvania
- +2 more
Dec 17, 2021
Pulmonary Arterial Hypertension, Pulmonary Hypertension, Interstitial Lung Disease Trial in Germany, United States (Bardoxolone
Completed
- Pulmonary Arterial Hypertension
- +11 more
- Bardoxolone methyl
- Placebo
-
Phoenix, Arizona
- +31 more
Nov 12, 2021
Scleroderma, Systemic, Sclerosis, Systemic, Systemic Scleroderma Trial in Worldwide (Pomalidomide (CC-4047), Placebo)
Terminated
- Scleroderma, Systemic
- +4 more
- Pomalidomide (CC-4047)
- Placebo
-
Los Angeles, California
- +55 more
Oct 16, 2019
Lung Tissue Research Consortium
Completed
- Chronic Obstructive Pulmonary Disease
- Interstitial Lung Disease
- Lung biopsy/lobectomy
-
Ann Arbor, Michigan
- +3 more
Mar 7, 2019